ORIONPHARM
Cat: ZPharmaceuticals and ChemicalsLive DSE SessionOrion Pharma Ltd.
Valuation Date: 2026-11-03 (Asia/Dhaka)
Decision overview
ORIONPHARM at a glance
Orion Pharma Ltd. · Pharmaceuticals and Chemicals · Category Z
Price
Metric৳26.90
As of 2026-11-03
Daily move
Market+0.75%
Compared with previous session
Trend vs SMA50
MetricAbove average
+0.19% vs SMA50
Volume activity
Metric0.11x
Compared with the previous 20 sessions
52-week position
Metric38.8%
৳22.90 low · ৳33.20 high
System view
Model🔒 Tier 4 Locked
Upgrade to Institutional AI (৳3,999/mo) to unlock
Unlock Technical Indicator Ratings & Mathematical Formulas
Unlock real-time multi-timeframe oscillators (RSI, Stochastic, MACD, ADX), trend evaluations, and 3-column deterministic formulas. Requires Tier 2 (Retail Active - ৳499/mo).
Unlock 7-Agent AI Consensus Intelligence Verdict
Master IQ dial, 30-day neural price trajectory models, probabilistic take-profit exit horizons, and Capital Guard stop loss require Tier 4 (Institutional AI - ৳3,999/mo).
Unlock Kronos Deep Neural 30-Day ML Price Forecast
Deep transformer neural network predicting 30-day future candlestick trajectory, confidence corridors, and expected volatility bounds requires Tier 4 (Institutional AI - ৳3,999/mo).
Unlock Top 10 Audited Strategy Research Signals
Systematic quantitative signals, machine-verified backtests, and algorithmic trading rules require Tier 4 (Institutional AI - ৳3,999/mo).
Unlock Accumulation / Distribution Money Flow Matrix
Track institutional accumulation/distribution patterns, Chaikin money flow, and volume-weighted whale buying. Requires Tier 3 (Quantitative Pro - ৳1,499/mo).
Historical Seasonality & Performance
Month-by-Month Seasonality & Historical Matrix
Historical month-by-month win rates and performance tendencies for ORIONPHARM on the Dhaka Stock Exchange.
ORIONPHARM Monthly Growth & Loss Matrix
Disclaimer & Sample Size LimitationsHistorical monthly tendencies represent past price changes and do not guarantee future returns. A small sample size over specific market regimes cannot predict forward performance.
| 12M Average | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Avg Return | -0.8% | +7.1% | -5.9% | -6.8% | +1.5% | +1.2% | -1.6% | +5.0% | +2.5% | -5.0% | -1.5% | +0.1% |
| Win Rate % | 46% | 69% | 14% | 15% | 50% | 43% | 43% | 57% | 43% | 14% | 36% | 39% |
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -3.6% | +18.4% | -5.0% | -11.7% | +2.4% | +7.1% | +1.1% | -9.4% | +12.1% | -2.4% | -1.5% | — |
| 2025 | -16.1% | +3.5% | -1.2% | -16.3% | -8.5% | +16.5% | +1.6% | +23.2% | -9.1% | -12.2% | -8.8% | -2.5% |
| 2024 | 0.0% | +1.6% | -9.9% | +0.6% | +3.0% | -3.1% | -7.7% | -27.0% | -24.7% | 0.0% | +0.5% | -3.3% |
| 2023 | +5.2% | -5.9% | -3.4% | -2.5% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| 2022 | +11.6% | -4.8% | +1.5% | -2.2% | -8.3% | -6.5% | -7.2% | +25.7% | +32.3% | -19.4% | -25.5% | -5.2% |
| 2021 | -20.0% | +6.8% | -14.3% | +6.5% | +6.3% | +5.7% | +5.3% | +11.5% | +33.3% | +10.6% | -4.5% | -12.2% |
| 2020 | +0.7% | +61.7% | -3.2% | — | 0.0% | -2.6% | +3.6% | +32.6% | -4.7% | -17.8% | -11.5% | +29.6% |
| 2019 | +2.2% | -3.4% | -8.5% | -5.9% | +1.8% | -2.4% | -5.0% | +0.3% | -10.2% | -4.7% | +9.0% | -7.2% |
| 2018 | -2.7% | +0.8% | +0.2% | -8.2% | -7.7% | +3.5% | +0.7% | -2.7% | -4.0% | -4.9% | -0.3% | +1.9% |
| 2017 | +13.8% | +7.3% | -7.0% | -7.2% | -2.2% | +5.0% | -1.8% | -1.6% | -2.8% | +3.0% | +0.6% | +0.8% |
| 2016 | -5.8% | +10.4% | -8.5% | -7.0% | +9.5% | -0.8% | +0.5% | +1.1% | +2.2% | -6.9% | +16.2% | +1.4% |
| 2015 | -6.1% | +2.1% | -3.4% | -22.7% | +26.6% | -3.5% | -2.2% | -4.6% | +3.0% | -8.9% | -0.9% | +5.7% |
| 2014 | +10.3% | -5.6% | -9.8% | -6.7% | -8.6% | -6.9% | -3.6% | +17.4% | +11.2% | 0.0% | -12.5% | -3.2% |
| 2013 | — | — | -10.2% | -5.1% | +6.3% | +5.3% | -8.3% | +3.0% | -3.7% | -6.0% | +17.9% | -5.3% |
Share Capital Structure & Ownership Distribution
Official regulatory depository holding breakdown for ORIONPHARM.
Ownership data will appear when the official DSE profile collector reaches this stock.
Official DSE Company Profile
Orion Pharma Ltd.
Trading Code: ORIONPHARM · Pharmaceuticals and Chemicals · Category: Z · Market Date: 2026-11-03
Current Price
৳26.90
Latest Volume
71,011
Day Turnover
৳1.91 mn
Executed Trades
138
52-Week High
৳33.20
52-Week Low
৳22.90
Face Value
Not available in current DSE dataset
Market Category
Z
Company Information and Valuation
Official DSE fields alongside imported AmarStock analytical snapshot.
Key Market Statistics & Vitals Matrix
Session Price Action & Liquidity
৳26.90
+0.75%
Unavailable
৳27.40
৳26.60
৳26.70
Annual Corridor & Execution Depth
৳33.20
৳22.90
630,651
71,011
৳1.91
138
Settlement-Aware Holding & Execution Reality
Failed AGMs, defaulted dividend payments, or negative reserves. T+3 settlement cycle. Day-trading or selling before demat delivery is legally blocked by Central Depository Bangladesh Ltd.
Captures short-term momentum pulses, catalyst earnings reactions, and volume breakouts.
Execution Friction & Break-Even Cost Accounting
Regulatory & Non-Guarantee Compliance Notice:
Statutory settlement cycles (T+2 / T+4) and investment horizons are risk-management and depository clearing parameters. They do NOT constitute a guaranteed profit recommendation, price prediction, or financial advice. Equities are subject to market risk, liquidity freezes, and capital loss.
DSE enforces daily circuit breaker limit bands (typically 10% on mainline, 20% on SME, 5% on low cap). Stop-losses are unexecutable if a stock locks at lower circuit or regulatory floor price with zero buyers.
Historical Price Table
3,239 Sessions• Latest: 2026-11-03 (৳26.90)Page 1 of 162Institutional Data Trust Panel Provenance Verified
2026-11-03
Asia/Dhaka canonicalDSE Day-End Archive
Dual-engine parallel sync0 Gaps (100% Continuity)
Calendar vs trading logHistorical prices reflect unadjusted trading records.
Market freshness
Current / expected delay
Market date: 2026-11-03
Official vs derived
DSE source + formula metrics
Ownership/fundamentals keep their own source dates below.
Input validation
Passed
OHLC issues: 0 · Negative volume: 0
Calculation version
v1
stock-metrics-v1 (SMA50, volume ratio, 52-week range)
UNIQUE(stock_id, date) duplicate prevention activeSymbol: ORIONPHARMExchange Cross-Check Verification 100% Parity
1-Minute real-time reconciliation comparing official DSE trades with secondary market feeds.